{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:41:08Z","timestamp":1793144468684,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004168","name":"Universit\u00e4t zu L\u00fcbeck","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004168","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic rhinosinusitis with nasal polyps (CRSwNP) is a common inflammatory disease causing considerable disease burden. The anti-inflammatory monoterpene 1,8-Cineol is a natural plant-based therapeutic agent that is well established to treat chronic and acute airway diseases. Aim of this study was to investigate whether the herbal drug 1,8-Cineol reaches the nasal tissue via the gut and the blood stream upon its oral administration. A highly sensitive gas chromatography mass spectrometry-based method with stir bar sorptive extraction (SBSE) for sample preparation has been developed and validated for the extraction, detection and quantification of 1,8-Cineol in tissue samples of nasal polyps from 30 CRSwNP patients. Data revealed a highly sensitive detection of 1,8-Cineol in nasal tissue samples after 14\u00a0days of oral administration of 1,8-Cineol prior to surgical treatment. There was no significant correlation between the measured 1,8-Cineol concentrations and bodyweight or BMI values of the analyzed patients, respectively. Our data indicate a systemic distribution of 1,8-Cineol in the human body after its oral administration. Individual differences in terms of metabolic characteristics and have to be further investigated. The study increases our understanding of the systemic effects of 1,8-Cineol upon its therapeutic application and benefit in patients with CRSwNP.<\/jats:p>","DOI":"10.1038\/s41598-023-29941-x","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T12:02:54Z","timestamp":1677844974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Determination of orally administered 1,8-Cineol in nasal polyp tissues from chronic rhinosinusitis patients using gas chromatography: mass spectrometry"],"prefix":"10.1038","volume":"13","author":[{"given":"Claire","family":"MacKenzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Goerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Buecking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Heidemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Leichtle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Ringbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"M\u00f6llenkolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ploch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Ludwig","family":"Bruchhage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Pries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"issue":"9","key":"29941_CR1","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","volume":"66","author":"D Hastan","year":"2011","unstructured":"Hastan, D. et al. Chronic rhinosinusitis in Europe\u2014An underestimated disease. A GA2LEN study. Allergy 66(9), 1216\u201323 (2011).","journal-title":"Allergy"},{"issue":"3","key":"29941_CR2","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jaci.2018.12.986","volume":"143","author":"D de Loos","year":"2019","unstructured":"de Loos, D. et al. Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology. J. Allergy Clin. Immunol. 143(3), 1207\u20131214 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"29941_CR3","doi-asserted-by":"crossref","unstructured":"Orlandi R, Kingdom T, Hwang P, Smith T, Alt J, Baroody F. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol.  S22\u2013S209 (2016).","DOI":"10.1002\/alr.21694"},{"issue":"1","key":"29941_CR4","first-page":"1","volume":"50","author":"W Fokkens","year":"2012","unstructured":"Fokkens, W. et al. European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. EPOS 50(1), 1\u201312 (2012).","journal-title":"EPOS"},{"issue":"11","key":"29941_CR5","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/all.12010","volume":"67","author":"R Pezato","year":"2012","unstructured":"Pezato, R. et al. Role of imbalance of eicosanoid pathways and staphylococcal superantigens in chronic rhinosinusitis. Allergy 67(11), 1347\u20131356 (2012).","journal-title":"Allergy"},{"issue":"5","key":"29941_CR6","first-page":"1087","volume":"130","author":"M Soyka","year":"2012","unstructured":"Soyka, M. et al. Defective epithelial barrier in chronic rhinosinusitis: The regulation of tight junctions by IFN-\u03b3 and IL-4. Allergy 130(5), 1087 (2012).","journal-title":"Allergy"},{"issue":"Suppl S29","key":"29941_CR7","first-page":"1","volume":"58","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens, W. J. et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 58(Suppl S29), 1\u2013464 (2020).","journal-title":"Rhinology."},{"key":"29941_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-210","author":"S Boase","year":"2013","unstructured":"Boase, S. et al. The microbiome of chronic rhinosinusitis: Culture, molecular diagnostics and biofilm detection. BMC Infect. Dis. https:\/\/doi.org\/10.1186\/1471-2334-13-210 (2013).","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"29941_CR9","first-page":"171","volume":"30","author":"P Tantilipikorn","year":"2012","unstructured":"Tantilipikorn, P., Bunnag, C., Nan, Z. & Bachert, C. Staphylococcus aureus superantigens and their role in eosinophilic nasal polyp disease. Asian Pac. J. Allergy Immunol. 30(3), 171\u2013176 (2012).","journal-title":"Asian Pac. J. Allergy Immunol."},{"issue":"16","key":"29941_CR10","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1080\/14656566.2018.1527904","volume":"19","author":"U Kucuksezer","year":"2018","unstructured":"Kucuksezer, U., Ozdemir, C., Akdis, M. & Akdis, C. Chronic rhinosinusitis: Pathogenesis, therapy options, and more. Expert Opin. Pharmacother. 19(16), 1805\u20131815 (2018).","journal-title":"Expert Opin. Pharmacother."},{"issue":"1","key":"29941_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00106-018-0557-7","volume":"67","author":"L Klimek","year":"2019","unstructured":"Klimek, L., Koennecke, M., Hagemann, J., Wollenberg, B. & Becker, S. Immunologie der Polyposis nasi als Grundlage f\u00fcr eine Therapie mit Biologicals [Immunology of chronic rhinosinusitis with nasal polyps as a basis for treatment with biologicals]. HNO 67(1), 15\u201326 (2019).","journal-title":"HNO"},{"issue":"24","key":"29941_CR12","doi-asserted-by":"publisher","first-page":"9477","DOI":"10.3390\/ijms21249477","volume":"21","author":"A Lyly","year":"2020","unstructured":"Lyly, A., Laulajainen-Hongisto, A., Gevaert, P., Kauppi, P. & Toppila-Salmi, S. Monoclonal antibodies and airway diseases. Int. J. Mol. Sci. 21(24), 9477 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"29941_CR13","first-page":"137","volume":"6","author":"S Asbaghian","year":"2011","unstructured":"Asbaghian, S., Shafaghat, A., Zarea, K., Kasimov, F. & Salimi, F. Comparison of volatile constituents, and antioxidant and antibacterial activities of the essential oils of Thymus caucasicus, T. kotschyanus and T. vulgaris. Nat. Prod. Commun. 6(1), 137\u201340 (2011).","journal-title":"Nat. Prod. Commun."},{"issue":"21","key":"29941_CR14","doi-asserted-by":"publisher","first-page":"10349","DOI":"10.1021\/jf901877x","volume":"57","author":"M Ben Farhat","year":"2009","unstructured":"Ben Farhat, M., Jordan, M. J., Chaouech-Hamada, R., Landoulsi, A. & Sotomayor, J. A. Variations in essential oil, phenolic compounds, and antioxidant activity of tunisian cultivated Salvia officinalis L. J. Agric. Food Chem. 57(21), 10349\u201310356 (2009).","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"29941_CR15","first-page":"81","volume":"31","author":"S Sertel","year":"2011","unstructured":"Sertel, S., Eichhorn, T., Plinkert, P. K. & Efferth, T. Cytotoxicity of Thymus vulgaris essential oil towards human oral cavity squamous cell carcinoma. Anticancer Res. 31(1), 81\u201387 (2011).","journal-title":"Anticancer Res."},{"issue":"3","key":"29941_CR16","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1053\/rmed.2003.1432","volume":"97","author":"UR Juergens","year":"2003","unstructured":"Juergens, U. R. et al. Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: A double-blind placebo-controlled trial. Respir. Med. 97(3), 250\u20136 (2003).","journal-title":"Respir. Med."},{"key":"29941_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1465-9921-10-69","volume":"10","author":"H Worth","year":"2009","unstructured":"Worth, H., Schacher, C. & Dethlefsen, U. Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial. Respir. Res. 10, 69 (2009).","journal-title":"Respir. Res."},{"issue":"5","key":"29941_CR18","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s12325-020-01279-0","volume":"37","author":"LJ Juergens","year":"2020","unstructured":"Juergens, L. J., Worth, H. & Juergens, U. R. New perspectives for mucolytic, anti-inflammatory and adjunctive therapy with 1,8-cineole in COPD and asthma: Review on the new therapeutic approach. Adv. Ther. 37(5), 1737\u20131753 (2020).","journal-title":"Adv. Ther."},{"issue":"1","key":"29941_CR19","doi-asserted-by":"publisher","first-page":"20940","DOI":"10.1038\/s41598-020-77039-5","volume":"10","author":"T Nakamura","year":"2020","unstructured":"Nakamura, T. et al. Eucalyptus oil reduces allergic reactions and suppresses mast cell degranulation by downregulating IgE-FcepsilonRI signalling. Sci. Rep. 10(1), 20940 (2020).","journal-title":"Sci. Rep."},{"issue":"1","key":"29941_CR20","first-page":"33","volume":"15","author":"AE Sadlon","year":"2010","unstructured":"Sadlon, A. E. & Lamson, D. W. Immune-modifying and antimicrobial effects of Eucalyptus oil and simple inhalation devices. Altern. Med. Rev. 15(1), 33\u201347 (2010).","journal-title":"Altern. Med. Rev."},{"issue":"11","key":"29941_CR21","first-page":"508","volume":"3","author":"U Juergens","year":"1998","unstructured":"Juergens, U., St\u00f6ber, M. & Vetter, H. Inhibition of cytokine production and arachidonic acid metabolism by eucalyptol (1.8-cineole) in human blood monocytes in vitro. Eur. J. Med. Res. 3(11), 508\u201310 (1998).","journal-title":"Eur. J. Med. Res."},{"key":"29941_CR22","doi-asserted-by":"publisher","first-page":"104706","DOI":"10.1155\/2012\/104706","volume":"2012","author":"A Ocana","year":"2012","unstructured":"Ocana, A. & Reglero, G. Effects of thyme extract oils (from Thymus vulgaris, Thymus zygis, and Thymus hyemalis) on cytokine production and gene expression of oxLDL-stimulated THP-1-macrophages. J. Obes. 2012, 104706 (2012).","journal-title":"J. Obes."},{"issue":"5","key":"29941_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pupt.2004.06.002","volume":"17","author":"U Juergens","year":"2004","unstructured":"Juergens, U. et al. Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes. Pulm. Pharmacol. Ther. 17(5), 281\u2013287 (2004).","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"1","key":"29941_CR24","doi-asserted-by":"publisher","first-page":"20824","DOI":"10.1038\/s41598-021-00249-y","volume":"11","author":"CL Moo","year":"2021","unstructured":"Moo, C. L. et al. Antimicrobial activity and mode of action of 1,8-cineol against carbapenemase-producing Klebsiella pneumoniae. Sci. Rep. 11(1), 20824 (2021).","journal-title":"Sci. Rep."},{"key":"29941_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejphar.2018.07.060","volume":"835","author":"KL Bruchhage","year":"2018","unstructured":"Bruchhage, K. L. et al. 1,8-cineol inhibits the Wnt\/beta-catenin signaling pathway through GSK-3 dephosphorylation in nasal polyps of chronic rhinosinusitis patients. Eur. J. Pharmacol. 835, 140\u2013146 (2018).","journal-title":"Eur. J. Pharmacol."},{"key":"29941_CR26","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.3389\/fmicb.2019.02325","volume":"10","author":"M Schurmann","year":"2019","unstructured":"Schurmann, M. et al. The therapeutic effect of 1,8-cineol on pathogenic bacteria species present in chronic rhinosinusitis. Front. Microbiol. 10, 2325 (2019).","journal-title":"Front. Microbiol."},{"issue":"5A","key":"29941_CR27","first-page":"3293","volume":"27","author":"MR Loizzo","year":"2007","unstructured":"Loizzo, M. R. et al. Cytotoxic activity of essential oils from labiatae and lauraceae families against in vitro human tumor models. Anticancer Res. 27(5A), 3293\u20133299 (2007).","journal-title":"Anticancer Res."},{"key":"29941_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fonc.2017.00092","volume":"7","author":"A Roettger","year":"2017","unstructured":"Roettger, A. et al. Inhibitory effect of 1,8-cineol on beta-catenin regulation, WNT11 expression, and cellular progression in HNSCC. Front. Oncol. 7, 92 (2017).","journal-title":"Front. Oncol."},{"issue":"3","key":"29941_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.bbagen.2004.12.019","volume":"1722","author":"M Duisken","year":"2005","unstructured":"Duisken, M., Sandner, F., Blomeke, B. & Hollender, J. Metabolism of 1,8-cineole by human cytochrome P450 enzymes: Identification of a new hydroxylated metabolite. Biochem. Biophys. Acta 1722(3), 304\u2013311 (2005).","journal-title":"Biochem. Biophys. Acta"},{"issue":"2","key":"29941_CR30","first-page":"200","volume":"29","author":"M Miyazawa","year":"2001","unstructured":"Miyazawa, M., Shindo, M. & Shimada, T. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes. Drug Metab. Dispos. 29(2), 200\u2013205 (2001).","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"29941_CR31","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/mnfr.200900528","volume":"54","author":"K Horst","year":"2010","unstructured":"Horst, K. & Rychlik, M. Quantification of 1,8-cineole and of its metabolites in humans using stable isotope dilution assays. Mol. Nutr. Food Res. 54(10), 1515\u20131529 (2010).","journal-title":"Mol. Nutr. Food Res."},{"issue":"4","key":"29941_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/chemse\/21.4.477","volume":"21","author":"W Jager","year":"1996","unstructured":"Jager, W. et al. Pharmacokinetic studies of the fragrance compound 1,8-cineol in humans during inhalation. Chem. Senses 21(4), 477\u2013480 (1996).","journal-title":"Chem. Senses"},{"key":"29941_CR33","doi-asserted-by":"publisher","first-page":"105113","DOI":"10.1016\/j.chemphyslip.2021.105113","volume":"239","author":"TS Lima","year":"2021","unstructured":"Lima, T. S. et al. Cineole-containing nanoemulsion: Development, stability, and antibacterial activity. Chem. Phys. Lipid. 239, 105113 (2021).","journal-title":"Chem. Phys. Lipid."},{"issue":"6","key":"29941_CR34","doi-asserted-by":"publisher","first-page":"e5080","DOI":"10.1002\/bmc.5080","volume":"35","author":"C Sa","year":"2021","unstructured":"Sa, C. et al. Quantification of eucalyptol (1,8-cineole) in rat serum by gas chromatography-mass\/mass spectrometry and its application to a rat pharmacokinetic study. Biomed. Chromatogr. 35(6), e5080 (2021).","journal-title":"Biomed. Chromatogr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29941-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29941-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29941-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T12:05:48Z","timestamp":1677845148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29941-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["29941"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-29941-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"assertion":[{"value":"13 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Thomas Goerke and Michael Ploch are working for the Cassella-med GmbH & Co. KG, Gereonsm\u00fchlengasse 1-11, 50670 K\u00f6ln, Germany, who funded the GLP study for the determination of 1,8-Cineol in cell lysates. The ordering party provided the 1,8-Cineol containing medication but had no influence on the conduction of the study, sampling, analysis, or data evaluation and acted as an advisor in the writing process and coordination of the study. Therefore, the results of this study are not biased by any possible conflict of interest. The other authors, Claire MacKenzie, Mark Buecking, Mathias Heidemann, Anke Leichtle, Benedikt Ringbeck, Friederike M\u00f6llenkolk, Karl-Ludwig Bruchhage and Ralph Pries, declare that the research was conducted in the absence of any conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3605"}}